UPCOMING EVENT
Jun. 3 - 7, 2023
San Diego
San Diego
Our proprietary platform technology and know-how allow us to extract and purify protein therapeutics from human plasma.
The unique properties and demonstrated clinical safety of AAT, render it an attractive therapeutic candidate for various medical conditions.
This video illustrates the mechanism of action of AAT, and its possible therapeutic effects.
Alpha-1 antitrypsin deficiency (AATD) is the most common hereditary disorder in adults. It is associated with an increased risk of developing pulmonary emphysema and liver disease, and also skin problems (panniculitis) and vasculitis.